Research across Cardiomyopathy
Related studies from across the Cardiomyopathy family.
Questions about Hypertrophic Cardiomyopathy
Which echocardiographic and biochemical markers can predict mortality risk for children with hypertrophic cardiomyopathy?
In children with hypertrophic cardiomyopathy, echocardiographic markers like left atrial size and left ventricular wall thickness, and biochemical markers such as NT-proBNP, predict mortality risk.
Full answer →Can visual standardized quantification of LGE help doctors see heart scarring better in hypertrophic cardiomyopathy?
Yes, VISTAQ, a visual standardized method, helps doctors see and quantify heart scarring (LGE) in HCM with excellent reproducibility, without needing complex software.
Full answer →All Hypertrophic Cardiomyopathy Articles
- Cardiac myosin inhibitors improve exercise capacity and health status in patients with hypertrophic cardiomyopathy
- AI-empowered echocardiography shows promise for HCM diagnosis and risk prediction, but validation is lacking
- Exercise improves cardiorespiratory fitness and quality of life in patients with hypertrophic cardiomyopathy
- Global Longitudinal Strain as a Potential Predictor of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
- Systematic review and meta-analysis of MYH7 versus MYBPC3 variants in obstructive hypertrophic cardiomyopathy
- Review of Visual Standardized Quantification for LGE in Cardiomyopathy
- Review synthesizes genetic insights and CMR imaging traits as potential therapeutic targets for cardiomyopathies
- Echocardiographic and biochemical markers predict mortality in children with hypertrophic cardiomyopathy
- Deep learning model improves LVOT obstruction classification in hypertrophic cardiomyopathy patients
- GWAS meta-analysis identifies 89 loci for mitral valve prolapse and genetic links to hypertrophic cardiomyopathy
- Plasma proteins linked to HCM severity identified in MYBPC3 carriers and UK Biobank
- Cardiac genetic testing mainstreaming increases uptake and reduces wait times but lowers informed decision making
- Multimodality cardiac imaging aids differentiation between hypertrophic cardiomyopathy and cardiac amyloidosis